Country Profile: Belgium
Recommendations
Children:
Children aged 2 to 12 months
At-risk groups:
All people aged 2 to 64 with asplenia or dysfunction of the spleen, chronic respiratory/heart/kidney/liver disease, diabetes, immunosuppression, cochlear implants and cerebrospinal fluid leaks
Older adults:
All people over the age of 65
Coverage figures
Children: 93.80% (2021)
At-risk groups: –
Older adults: 10.60%* (2013)
Vaccination advisory body/committee
Belgian National Immunisation Technical Advisory Group
Notes:
*Figure is an average of two age groups: 10.00% in people aged 65-84 years and 11.20% in people aged >85 years.
Sources:
Children
WHO: https://immunizationdata.who.int/pages/coverage/pcv.html?CODE=BEL&ANTIGEN=PCV1+PCV2+PCV3&YEAR=
Older adults:
Belgian Health Care Knowledge Centre: https://kce.fgov.be/sites/default/files/2021-11/KCE_274C_Short-Report_Pneumococcal.pdf
Children
ECDC vaccine scheduler: https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=25&SelectedCountryIdByDisease=269
At-risk groups:
ECDC vaccine scheduler: https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=25&SelectedCountryIdByDisease=269
Older adults:
ECDC vaccine scheduler: https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=25&SelectedCountryIdByDisease=269
Older adults aged 65 and over: vaccination is recommended but not funded by the National Health system.
Report an issue: Something doesn’t look right? Contact us